NDC 50242-177 – Lunsumio Velo

Mosunetuzumab 5 mg/.5mL · Injection · Subcutaneous

Human Prescription Drug

Product NDC50242-177

Product details

Brand name
Lunsumio Velo
Generic name
Mosunetuzumab
Labeler
Genentech, Inc.
Dosage form
Injection
Route
Subcutaneous
Marketing category
BLA · BLA761263
Marketed since
December 19, 2025
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Lunsumio Velo →

Package NDC codes (1)

Package NDCDescriptionSince
50242-177-011 VIAL, GLASS in 1 CARTON (50242-177-01) / .5 mL in 1 VIAL, GLASSDec 19, 2025

Other Lunsumio Velo products